This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Merck Sharp + Dohme Corp., Prism Pharma Co., Ltd.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (2022)
- Tokyo, JP (2023 - 2024)
Company Filing History:
4 out of 530 
2 out of 2,405 
1 out of 5 
Years Active: 2022-2025
Title: Yusaku Hori: Innovator in Cancer Treatment
Introduction
Yusaku Hori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 4 patents, Hori's work focuses on innovative therapeutic compositions that aim to improve patient outcomes.
Latest Patents
Hori's latest patents include a tumor-treating pharmaceutical composition that combines lenvatinib with a specific compound designed to target tumors effectively. This composition is intended for use in combination therapy, enhancing the efficacy of existing treatments. Another notable patent involves a combination of a PD-1 antagonist and a multi-RTK inhibitor for treating cancer. This innovative approach aims to leverage the strengths of both therapies to provide a more effective treatment option for patients.
Career Highlights
Throughout his career, Hori has worked with leading companies in the pharmaceutical industry, including Eisai R&D Management Co., Ltd. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to develop groundbreaking therapies that address critical health challenges.
Collaborations
Hori has collaborated with notable professionals in his field, including Andrew Evan Denker and Yu Kato. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yusaku Hori's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions continue to pave the way for new therapeutic options that can significantly improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile